by Medicine by Design | Oct 18, 2024
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This portrait is one in a series of portraits that feature “people of Medicine by Design.” Some minor...
by Medicine by Design | Apr 22, 2024
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This profile is one in a series of proflies that feature “people” of Medicine by Design. Some minor edits...
by Tara Fernandez | Oct 17, 2019
RNA-based vaccines have been heralded as a new molecular weapon in the arsenal against cancer and infections. Five years ago, they were thrust into the spotlight following a $52 million investment by the Bill and Melinda Gates Foundation to CureVac, a...
by Stacey Johnson | Oct 4, 2019
One of the speakers invited to the Current Trends in Biotherapeutics Workshop, hosted by the Clinical Translation Education Group (CTEG),* was Alexandre Le Bouthillier, co-founder of Imagia. This Montreal-based company is harnessing the power of artificial...
Comments